The synthetic artificial stem cell (SASC): Shifting the paradigm of cell therapy in regenerative engineering
Open Access
- 5 January 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (2)
Abstract
Significance: This paper presents the synthetic artificial stem cell (SASC) system: a versatile therapy which provides the ability to tailor paracrine responses of different cells and provide a more potent regenerative effect for targeted tissues. Upon challenging the SASC system against an osteoarthritis model, we demonstrate that the factors combined tailored for chondrogenesis have a potent antiinflammatory and chondroprotective effect. This paper also demonstrates the in vivo capacity of SASC to attenuate proteoglycan depletion in the cartilage extracellular matrix while also improving biomechanical properties of the resulting cartilage. We report the first of many applications of the SASC system, which provides a promising step toward clinical translation of a minimally immunogenic stem cell with many commercial advantages over its biological counterpart.Keywords
Funding Information
- HHS | National Institutes of Health (DP1AR068147)
- HHS | National Institutes of Health (T32 AR079114)
This publication has 65 references indexed in Scilit:
- Intra-articular injection of collagenase in the knee of rats as an alternative model to study nociception associated with osteoarthritisArthritis Research & Therapy, 2014
- Fibroblast growth factor control of cartilage homeostasisJournal of Cellular Biochemistry, 2012
- The impact of anterior cruciate ligament injury on lubricin metabolism and the effect of inhibiting tumor necrosis factor α on chondroprotection in an animal modelArthritis & Rheumatism, 2009
- The Interleukin 1β Pathway in the Pathogenesis of OsteoarthritisThe Journal of Rheumatology, 2008
- Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injuryArthritis & Rheumatism, 2008
- Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffoldsBiomaterials, 2008
- Coefficients of friction, lubricin, and cartilage damage in the anterior cruciate ligament‐deficient guinea pig kneeJournal of Orthopaedic Research, 2007
- TGF‐β1 suppresses IFN‐γ‐induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradationGenes to Cells, 2006
- Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion techniqueJournal of Microencapsulation, 2005
- Nitric oxide decreases IGF-1 receptor function in vitro; glutathione depletion enhances this effect in vivoOsteoarthritis and Cartilage, 2004